Pulmonary hypertension (PH) describes a hemodynamic condition with a pathological increase in pressure in the pulmonary vascular circulation. Clinically, PH causes reduced performance, shortness of breath, angina and syncope. Comprehensive diagnostics to exclude or classify the various underlying clinical pictures is essential, as the treatment of pulmonary hypertension sometimes differs considerably depending on the underlying disease.
Autoren
- Dr. med. Yaosi Li
- Dr. med. Daniel Grund
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Ulcerative colitis: current evidence on anti-inflammatory therapies
Remission induction and maintenance with biologics and JAK-i
- Bronchiectasis
New strategies against neutrophilic inflammation
- IBD in childhood
Pneumococcal vaccination without negative consequences
- Seborrheic Dermatitis in Adults and Adolescents
Current State of Knowledge and New Therapeutic Approaches
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Orthobiologics for knee osteoarthritis
PRP and hyaluronic acid injections as building blocks in a multimodal concept
- Soft tissue sarcomas of the lower extremity
Diagnostics, subtypes and treatment options
- Psychological dependence on AI assistants, smartphones and short videos